ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,69
-0,68%
Dow Jones
40 787,65
1,43%
DAX
18 514,24
-0,46%
Brent Oil
83,565
-0,92%
Bitcoin
63 718,40
-1,75%
Registration Strip Icon for discussion Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Royaume-Uni
  5. LSE
  6. Hutchison China Meditech Ltd (0J7G)

  7. Hutchison China Meditech Ltd (0J7G) Actualités

0J7G

Hutchison China Meditech (0J7G)

Hutchison China Meditech Ltd
De:
Trier par:
 Showing the most relevant articles for your search:LSE:0J7G
DateHeureSourceTitreSymboleSociété
03/02/202108h00UK RegulatoryHutchison China Meditech Limited Notice of ResultsLSE:0J7GHutchison China Meditech Ltd
14/01/202111h00RNS Non-RegulatoryHutchison China Meditech Limited Savolitinib Data to be Presented at Virtual WCLCLSE:0J7GHutchison China Meditech Ltd
11/01/202108h00RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med & Inmagene Announce Strategic PartnershipLSE:0J7GHutchison China Meditech Ltd
31/12/202008h00UK RegulatoryHutchison China Meditech Limited Total Voting RightsLSE:0J7GHutchison China Meditech Ltd
31/12/202008h00UK RegulatoryHutchison China Meditech Limited Blocklisting Six Monthly ReturnLSE:0J7GHutchison China Meditech Ltd
30/12/202013h00UK RegulatoryHutchison China Meditech Limited NMPA approval of Surufatinib in China for ep-NETLSE:0J7GHutchison China Meditech Ltd
29/12/202008h45RNS Non-RegulatoryHutchison China Meditech Limited US NDA Rolling Submission of Surufatinib InitiatedLSE:0J7GHutchison China Meditech Ltd
22/12/202008h00RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med to Present at JPMLSE:0J7GHutchison China Meditech Ltd
15/12/202010h45UK RegulatoryHutchison China Meditech Limited Grant of Share Options under Share Option SchemeLSE:0J7GHutchison China Meditech Ltd
27/11/202008h00UK RegulatoryHutchison China Meditech Limited Notification of Dilution of Voting RightsLSE:0J7GHutchison China Meditech Ltd
17/11/202008h00UK RegulatoryHutchison China Meditech Limited US$100m Equity Investment by CPP InvestmentsLSE:0J7GHutchison China Meditech Ltd
05/11/202010h00RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med to Present HMPL-689 Clinical Data at ASHLSE:0J7GHutchison China Meditech Ltd
30/10/202013h00RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med to Attend Upcoming ConferencesLSE:0J7GHutchison China Meditech Ltd
21/09/202008h00RNS Non-RegulatoryHutchison China Meditech Limited Surufatinib Data at ESMO and in Lancet OncologyLSE:0J7GHutchison China Meditech Ltd
17/09/202012h45RNS Non-RegulatoryHutchison China Meditech Limited Second Chinese NDA Acceptance for SurufatinibLSE:0J7GHutchison China Meditech Ltd
04/09/202008h00RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Initiates Global Phase III TrialLSE:0J7GHutchison China Meditech Ltd
03/09/202008h00RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Initiates a Phase II TrialLSE:0J7GHutchison China Meditech Ltd
24/08/202008h00RNS Non-RegulatoryHutchison China Meditech Limited Clinical Data to be Presented at ESMO 2020LSE:0J7GHutchison China Meditech Ltd
10/08/202008h00RNS Non-RegulatoryHutchison China Meditech Limited Surufatinib Marketing Authorization ApplicationLSE:0J7GHutchison China Meditech Ltd
30/07/202013h00UK RegulatoryHutchison China Meditech Limited Interim Results and Clinical UpdateLSE:0J7GHutchison China Meditech Ltd
30/07/202008h00UK RegulatoryHutchison China Meditech Limited Block Admission ApplicationLSE:0J7GHutchison China Meditech Ltd
28/07/202008h00RNS Non-RegulatoryHutchison China Meditech Limited Savolitinib NDA Granted Priority Review in ChinaLSE:0J7GHutchison China Meditech Ltd
28/07/202008h00UK RegulatoryHutchison China Meditech Limited Chi-Med & Lilly Collaborate on Elunate in ChinaLSE:0J7GHutchison China Meditech Ltd
24/07/202008h00RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med Initiates HMPL-306 Phase I Trial in ChinaLSE:0J7GHutchison China Meditech Ltd
08/07/202009h00UK RegulatoryHutchison China Meditech Limited Holding(s) in CompanyLSE:0J7GHutchison China Meditech Ltd
26/05/202008h01RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med and BeiGene Enter Clinical CollaborationLSE:0J7GHutchison China Meditech Ltd
14/05/202008h00RNS Non-RegulatoryHutchison China Meditech Limited Clinical Data to be Presented at ASCO20LSE:0J7GHutchison China Meditech Ltd
11/05/202017h41UK RegulatoryHutchison China Meditech Limited Second Price Monitoring ExtnLSE:0J7GHutchison China Meditech Ltd
11/05/202017h36UK RegulatoryHutchison China Meditech Limited Price Monitoring ExtensionLSE:0J7GHutchison China Meditech Ltd
11/05/202008h00RNS Non-RegulatoryHutchison China Meditech Limited Chi-Med to Attend Upcoming Investor ConferencesLSE:0J7GHutchison China Meditech Ltd
 Showing the most relevant articles for your search:LSE:0J7G

Dernières Valeurs Consultées

BIT
W0F192
UBS
BIT
UB5FVN
Unicredit Bank
BIT
UC8FQX
Unicredit Bank
NASDAQ
EXFO
EXFO
LSE
EMV
Ishr Em Mv
NASDAQ
KVHI
KVH Industries
LSE
XDN0
Xnordic
NASDAQ
PSEC
Prospect Capital
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés